Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1089/AID.2021.0005 http://scihub22266oqcxt.onion/10.1089/AID.2021.0005 33587013!8312028!33587013     free     free     free Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       AIDS+Res+Hum+Retroviruses 2021 ; 37 (8): 589-600 Nephropedia Template TP {{tp|p=33587013|t=2021. Pressing Questions and Challenges in the HIV-1 and SARS-CoV-2 Syndemic |pdf=|usr=}}{{33587013}} gab.com Text Pressing Questions and Challenges in the HIV-1 and SARS-CoV-2 Syndemic JO: AIDS Res Hum Retroviruses http://www.kidney.de/pget.php?&tw=1&pmid=33587013 #FOAvip Since emerging into the human population in late 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has reached across the globe to infect >80 million people. The coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 can range in severity from mild and asymptomatic to severe and fatal. Identifying risk factors for adverse outcomes in COVID-19 is a major challenge. In the context of the existing HIV-1 pandemic, whether COVID-19 disproportionately burdens people living with HIV-1 infection (PLWH) is unclear. The following discussion highlights pressing questions and challenges in the HIV-1 and SARS-CoV-2 syndemic, including (i) age, sex, and race as drivers of COVID-19 severity; (ii) whether chronic inflammation common in PLWH influences immune response; (iii) whether disease severity and trajectory models for COVID-19 ought to be calibrated for PLWH; (iv) vaccine considerations, and finally, (v) long-term health outcomes in PLWH that are further burdened by coinfection with SARS-CoV-2. Twit Text FOAVip Pressing Questions and Challenges in the HIV-1 and SARS-CoV-2 Syndemic ????AIDS Res Hum Retroviruses http://www.kidney.de/pget.php?&tw=1&pmid=33587013 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33587013 #FOAvip English Wikipedia <ref>{{Cite pmid|33587013}}</ref> Pressing Questions and Challenges in the HIV-1 and SARS-CoV-2 Syndemic #MMPMID33587013 Montano M AIDS Res Hum Retroviruses 2021[Aug]; 37 (8): 589-600 PMID33587013show ga Since emerging into the human population in late 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has reached across the globe to infect >80 million people. The coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 can range in severity from mild and asymptomatic to severe and fatal. Identifying risk factors for adverse outcomes in COVID-19 is a major challenge. In the context of the existing HIV-1 pandemic, whether COVID-19 disproportionately burdens people living with HIV-1 infection (PLWH) is unclear. The following discussion highlights pressing questions and challenges in the HIV-1 and SARS-CoV-2 syndemic, including (i) age, sex, and race as drivers of COVID-19 severity; (ii) whether chronic inflammation common in PLWH influences immune response; (iii) whether disease severity and trajectory models for COVID-19 ought to be calibrated for PLWH; (iv) vaccine considerations, and finally, (v) long-term health outcomes in PLWH that are further burdened by coinfection with SARS-CoV-2. |*HIV-1[MESH] |*SARS-CoV-2[MESH] |*Syndemic[MESH] |COVID-19/*epidemiology[MESH] |Female[MESH] |HIV Infections/*epidemiology[MESH] |Humans[MESH] |Male[MESH]Pressing Questions and Challenges in the HIV-1 and SARS-CoV-2 Syndemic(epmc).pdf DeepDyve Pubget Overpricing